Obstructive Sleep Apnoea in Adolescents With Thoracic Aortic Aneurysm
NCT ID: NCT03400319
Last Updated: 2021-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
174 participants
OBSERVATIONAL
2014-07-05
2020-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Is Obstructive Sleep Apnoea a Risk Factor for Thoracic Aortic Aneurysm Expansion? A Prospective Cohort Study.
NCT02204774
Sleep and Stent Study: a Multicentre, Prospective Study
NCT02215317
Identification of Sleep-Disordered Breathing in Children
NCT00233194
The Impact of Obstructive Sleep Apnea on the Outcomes in Patients of First-Time Acute Myocardial Infarction
NCT00854997
A Research Study for Children About Heart Changes and Obstructive Sleep Apnea (OSA)
NCT01837459
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Thoracic Aortic Aneurysm
Patients with Thoracic Aortic Aneurysm: Women: at the level of the sinus of valsalva ≥39mm, or ascending aorta ≥42mm. Men: at the level of the sinus of valsalva ≥44mm, or ascending aorta ≥46mm.
No interventions assigned to this group
No Thoracic Aortic Aneurysm
Patients without Thoracic Aortic Aneurysm: Women: at the level of the sinus of valsalva \<39mm, or ascending aorta \<42mm. Men: at the level of the sinus of valsalva \<44mm, or ascending aorta \<46mm.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of thoracic aortic aneurysm defined by the following parameters:
Women: at the level of the sinus of valsalva ≥39mm, or ascending aorta ≥42mm. (for controls: \<39mm and \<42mm respectively); Men: at the level of the sinus of valsalva ≥44mm, or ascending aorta ≥46mm. (for controls: \<44mm and \<46mm respectively)
Exclusion Criteria
* Patients with known central sleep apnoea.
* Patients on morphine or other opioid medication, heroin addiction, alcohol addiction.
* Patients with moderate or severe aortic regurgitation.
* Patients with moderate or severe aortic stenosis.
* Pregnant patients.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Zurich, Pulmonary Division
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KEK-ZH-Nr. 2014-0035 CTRL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.